J. C. Rodríguez Rey
431
41.
Brown, M.S., and Goldstein, J.L. 1997. The SREBP pathway: regulation of cholesterol
metabolism by proteolysis of a membrane-‐bound transcription factor.
Cell
89:331-‐340.
42.
Horton, J.D., Goldstein, J.L., and Brown, M.S. 2002. SREBPs: activators of the complete
program of cholesterol and fatty acid synthesis in the liver.
J Clin Invest
109:1125-‐1131.
43.
Biddinger, S.B., Hernandez-‐Ono, A., Rask-‐Madsen, C., Haas, J.T., Aleman, J.O., Suzuki, R.,
Scapa, E.F., Agarwal, C., Carey, M.C., Stephanopoulos, G., et al. 2008. Hepatic insulin
resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis.
Cell
Metab
7:125-‐134.
44.
Michael, M.D., Kulkarni, R.N., Postic, C., Previs, S.F., Shulman, G.I., Magnuson, M.A., and
Kahn, C.R. 2000. Loss of insulin signaling in hepatocytes leads to severe insulin resistance
and progressive hepatic dysfunction.
Mol Cell
6:87-‐97.
45.
Shimomura, I., Matsuda, M., Hammer, R.E., Bashmakov, Y., Brown, M.S., and Goldstein, J.L.
2000. Decreased IRS-‐2 and increased SREBP-‐1c lead to mixed insulin resistance and
sensitivity in livers of lipodystrophic and ob/ob mice.
Mol Cell
6:77-‐86.
46.
Brown, M.S., and Goldstein, J.L. 2008. Selective versus total insulin resistance: a pathogenic
paradox.
Cell Metab
7:95-‐96.
47.
Tran, H., Brunet, A., Griffith, E.C., and Greenberg, M.E. 2003. The many forks in FOXO's road.
Sci STKE
2003:RE5.
48.
Li, S., Brown, M.S., and Goldstein, J.L. 2010. Bifurcation of insulin signaling pathway in rat
liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of
gluconeogenesis.
Proc Natl Acad Sci U S A
107:3441-‐3446.
49.
Pajvani, U.B., Qiang, L., Kangsamaksin, T., Kitajewski, J., Ginsberg, H.N., and Accili, D. 2013.
Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by
decreasing mTorc1 stability.
Nat Med
19:1054-‐1060.
50.
Li, Y., Xu, S., Mihaylova, M.M., Zheng, B., Hou, X., Jiang, B., Park, O., Luo, Z., Lefai, E., Shyy, J.Y.,
et al. 2011. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic
steatosis and atherosclerosis in diet-‐induced insulin-‐resistant mice.
Cell Metab
13:376-‐388.
51.
Liu, L., Zhang, Y., Chen, N., Shi, X., Tsang, B., and Yu, Y.H. 2007. Upregulation of myocellular
DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-‐
induced insulin resistance.
J Clin Invest
117:1679-‐1689.
52.
Goodpaster, B.H., He, J., Watkins, S., and Kelley, D.E. 2001. Skeletal muscle lipid content
and insulin resistance: evidence for a paradox in endurance-‐trained athletes.
J Clin
Endocrinol Metab
86:5755-‐5761.
53.
Samuel, V.T., and Shulman, G.I. 2012. Mechanisms for insulin resistance: common threads
and missing links.
Cell
148:852-‐871.
54.
Holland, W.L., Brozinick, J.T., Wang, L.P., Hawkins, E.D., Sargent, K.M., Liu, Y., Narra, K.,
Hoehn, K.L., Knotts, T.A., Siesky, A., et al. 2007. Inhibition of ceramide synthesis
ameliorates glucocorticoid-‐, saturated-‐fat-‐, and obesity-‐induced insulin resistance.
Cell
Metab
5:167-‐179.
55.
Haring, H., Kirsch, D., Obermaier, B., Ermel, B., and Machicao, F. 1986. Tumor-‐promoting
phorbol esters increase the Km of the ATP-‐binding site of the insulin receptor kinase from
rat adipocytes.
J Biol Chem
261:3869-‐3875.
56.
Avignon, A., Yamada, K., Zhou, X., Spencer, B., Cardona, O., Saba-‐Siddique, S., Galloway, L.,
Standaert, M.L., and Farese, R.V. 1996. Chronic activation of protein kinase C in soleus
muscles and other tissues of insulin-‐resistant type II diabetic Goto-‐Kakizaki (GK),
obese/aged, and obese/Zucker rats. A mechanism for inhibiting glycogen synthesis.
Diabetes
45:1396-‐1404.
57.
Griffin, M.E., Marcucci, M.J., Cline, G.W., Bell, K., Barucci, N., Lee, D., Goodyear, L.J., Kraegen,
E.W., White, M.F., and Shulman, G.I. 1999. Free fatty acid-‐induced insulin resistance is
associated with activation of protein kinase C theta and alterations in the insulin signaling
cascade.
Diabetes
48:1270-‐1274.
